Tumor Tolerance–Promoting Function of Regulatory T Cells Is Optimized by CD28, but Strictly Dependent on Calcineurin

Regulatory T cells (Treg) restrain immune responses against malignant tumors, but their global depletion in cancer patients will likely be limited by systemic autoimmune toxicity. Instead, approaches to “tune” their activities may allow for preferential targeting of tumor-reactive Treg. Although Ag recognition regulates Treg function, the roles of individual TCR-dependent signaling pathways in enabling Treg to promote tumor tolerance are not well characterized. In this study, we examined in mouse tumor models the role of calcineurin, a key mediator of TCR signaling, and the role of the costimulatory receptor CD28 in the differentiation of resting central Treg into effector Treg endowed with tumor tropism. We find that calcineurin, although largely dispensable for suppressive activity in vitro, is essential for upregulation of ICOS and CTLA-4 in Treg, as well as for expression of chemokine receptors driving their accumulation in tumors. In contrast, CD28 is not critical, but optimizes the formation of tumor-homing Treg and their fitness in tumor tissue. Accordingly, although deletion of either CnB or CD28 strongly impairs Treg-mediated tumor tolerance, lack of CnB has an even more pronounced impact than lack of CD28. Hence, our studies reveal distinct roles for what has classically been defined as signal 1 and signal 2 of conventional T cell activation in the context of Treg-mediated tumor tolerance.

[1]  Kelsey K. Finn,et al.  B Cells Drive Autoimmunity in Mice with CD28-Deficient Regulatory T Cells , 2017, The Journal of Immunology.

[2]  W. Shi,et al.  The TNF Receptor Superfamily-NF-κB Axis Is Critical to Maintain Effector Regulatory T Cells in Lymphoid and Non-lymphoid Tissues. , 2017, Cell reports.

[3]  R. Rabadán,et al.  An NF-κB Transcription-Factor-Dependent Lineage-Specific Transcriptional Program Promotes Regulatory T Cell Identity and Function. , 2017, Immunity.

[4]  U. Klein,et al.  NF-κB c-Rel Is Crucial for the Regulatory T Cell Immune Checkpoint in Cancer , 2017, Cell.

[5]  G. Plitas,et al.  Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer. , 2016, Immunity.

[6]  H. Stunnenberg,et al.  Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells , 2016, Immunity.

[7]  D. Campbell,et al.  A 33D1+ Dendritic Cell/Autoreactive CD4+ T Cell Circuit Maintains IL-2–Dependent Regulatory T Cells in the Spleen , 2016, The Journal of Immunology.

[8]  J. Luke,et al.  Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial , 2016, Journal of Immunotherapy for Cancer.

[9]  A. Rao,et al.  Cutting Edge: NFAT Transcription Factors Promote the Generation of Follicular Helper T Cells in Response to Acute Viral Infection , 2016, The Journal of Immunology.

[10]  A. Toure,et al.  Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity , 2016, Nature.

[11]  B. Nogrady.  Q&A: Declan Murphy , 2015, Nature.

[12]  T. Mempel,et al.  In the right place at the right time , 2015, Nature.

[13]  Ronald N. Germain,et al.  Immune homeostasis enforced by co-localized effector and regulatory T cells , 2015, Nature.

[14]  M. Fischbach,et al.  A Wave of Regulatory T Cells into Neonatal Skin Mediates Tolerance to Commensal Microbes. , 2015, Immunity.

[15]  C. Benoist,et al.  Imbalanced signal transduction in regulatory T cells expressing the transcription factor FoxP3 , 2015, Proceedings of the National Academy of Sciences.

[16]  C. Leslie,et al.  A mechanism for expansion of regulatory T cell repertoire and its role in self tolerance , 2015, Nature.

[17]  L. Turka,et al.  Requirement for CD28 in Effector Regulatory T Cell Differentiation, CCR6 Induction, and Skin Homing , 2015, The Journal of Immunology.

[18]  H. Lähdesmäki,et al.  The transcription factor NFAT promotes exhaustion of activated CD8⁺ T cells. , 2015, Immunity.

[19]  A. Rosenwald,et al.  Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity , 2015, Proceedings of the National Academy of Sciences.

[20]  Marco Y. Hein,et al.  Continuous T cell receptor signals maintain a functional regulatory T cell pool. , 2014, Immunity.

[21]  C. Benner,et al.  Function of a Foxp3 cis-Element in Protecting Regulatory T Cell Identity , 2014, Cell.

[22]  Dalya R. Soond,et al.  Inactivation of the PI3K p110δ breaks regulatory T cell-mediated immune tolerance to cancer , 2014, Nature.

[23]  Edward Y Kim,et al.  Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction. , 2014, The Journal of clinical investigation.

[24]  F. Berberich-Siebelt,et al.  Follicular regulatory T cells control humoral autoimmunity via NFAT2-regulated CXCR5 expression , 2014, The Journal of experimental medicine.

[25]  D. Campbell,et al.  CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets , 2014, The Journal of experimental medicine.

[26]  J. Karbach,et al.  Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans , 2013, Proceedings of the National Academy of Sciences.

[27]  D. Finkelstein,et al.  Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis , 2013, Nature.

[28]  T. Denning,et al.  Thymus-derived regulatory T cells control tolerance to commensal microbiota , 2013, Nature.

[29]  Edward Y. Kim,et al.  The transcription factor NFAT exhibits signal memory during serial T cell interactions with antigen-presenting cells. , 2013, Immunity.

[30]  K. Baumann.  Development: Growing a blood vessel network , 2013, Nature Reviews Molecular Cell Biology.

[31]  L. Turka,et al.  An obligate cell-intrinsic function for CD28 in Tregs. , 2013, The Journal of clinical investigation.

[32]  S. Goebbels,et al.  Cell‐intrinsic and ‐extrinsic control of Treg‐cell homeostasis and function revealed by induced CD28 deletion , 2013, European journal of immunology.

[33]  R. Zahedi,et al.  An alternative NFAT-activation pathway mediated by IL-7 is critical for early thymocyte development , 2012, Nature Immunology.

[34]  Shane J. Neph,et al.  Foxp3 Exploits a Pre-Existent Enhancer Landscape for Regulatory T Cell Lineage Specification , 2012, Cell.

[35]  A. Waisman,et al.  Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cells , 2012, Proceedings of the National Academy of Sciences.

[36]  K. Odunsi,et al.  CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity. , 2012, Cancer research.

[37]  S. Singhal,et al.  Inhibition of p300 impairs Foxp3+ T-regulatory cell function and promotes anti-tumor immunity , 2013, Nature Medicine.

[38]  A. Shakya,et al.  Constitutive Nuclear Localization of NFAT in Foxp3+ Regulatory T Cells Independent of Calcineurin Activity , 2012, The Journal of Immunology.

[39]  R. Marienfeld,et al.  The Ca2+-dependent Phosphatase Calcineurin Controls the Formation of the Carma1-Bcl10-Malt1 Complex during T Cell Receptor-induced NF-κB Activation* , 2011, The Journal of Biological Chemistry.

[40]  A. Abbas,et al.  Cutting Edge: Mechanisms of IL-2–Dependent Maintenance of Functional Regulatory T Cells , 2010, The Journal of Immunology.

[41]  Christophe Benoist,et al.  Stability of the Regulatory T Cell Lineage in Vivo , 2010, Science.

[42]  S. Ghosh,et al.  Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. , 2009, Immunity.

[43]  M. Greene,et al.  Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. , 2009, Immunity.

[44]  D. Klatzmann,et al.  Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice. , 2009, The Journal of clinical investigation.

[45]  Michael L. Dustin,et al.  Feedback control of regulatory T cell homeostasis by dendritic cells in vivo , 2009, The Journal of experimental medicine.

[46]  Peter O. Krutzik,et al.  The Initial Phase of an Immune Response Functions to Activate Regulatory T Cells1 , 2009, The Journal of Immunology.

[47]  Daniel J. Campbell,et al.  T-bet controls regulatory T cell homeostasis and function during type-1 inflammation , 2009, Nature Immunology.

[48]  T. Eberlein,et al.  Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer1 , 2009, The Journal of Immunology.

[49]  M. Kasuga,et al.  Phosphoinositide-dependent kinase 1 integrates T cell receptor and CD28 co-receptor signaling to effect NF-κB induction and T cell activation , 2009, Nature Immunology.

[50]  T. Nomura,et al.  CTLA-4 Control over Foxp3+ Regulatory T Cell Function , 2008, Science.

[51]  E. Chi,et al.  Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. , 2008, Immunity.

[52]  T. Sumpter,et al.  Regulation of the NFAT pathway discriminates CD4+CD25+ regulatory T cells from CD4+CD25− helper T cells , 2008, Journal of leukocyte biology.

[53]  Hosung Jung,et al.  Activation of the nuclear factor of activated T-cells (NFAT) mediates upregulation of CCR2 chemokine receptors in dorsal root ganglion (DRG) neurons: A possible mechanism for activity-dependent transcription in DRG neurons in association with neuropathic pain , 2008, Molecular and Cellular Neuroscience.

[54]  C. Hsieh,et al.  A two-step process for thymic regulatory T cell development. , 2008, Immunity.

[55]  A. Rudensky,et al.  Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease , 2007, The Journal of experimental medicine.

[56]  S. Semprini,et al.  Cryptic loxP sites in mammalian genomes: genome-wide distribution and relevance for the efficiency of BAC/PAC recombineering techniques , 2007, Nucleic acids research.

[57]  A. Rudensky,et al.  Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice , 2007, Nature Immunology.

[58]  S. Kang,et al.  FoxP3+ T Cells Undergo Conventional First Switch to Lymphoid Tissue Homing Receptors in Thymus but Accelerated Second Switch to Nonlymphoid Tissue Homing Receptors in Secondary Lymphoid Tissues1 , 2007, The Journal of Immunology.

[59]  C. Blank,et al.  Immune resistance orchestrated by the tumor microenvironment , 2006, Immunological reviews.

[60]  L. Turka,et al.  Defective Activation of Protein Kinase C and Ras-ERK Pathways Limits IL-2 Production and Proliferation by CD4+CD25+ Regulatory T Cells1 , 2006, The Journal of Immunology.

[61]  J. Stroud,et al.  FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT , 2006, Cell.

[62]  Christopher H Contag,et al.  Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. , 2006, Blood.

[63]  L. Kane,et al.  CARMA1 Is Required for Akt-Mediated NF-κB Activation in T Cells , 2006, Molecular and Cellular Biology.

[64]  J. She,et al.  Physiologic self antigens rapidly capacitate autoimmune disease-specific polyclonal CD4+ CD25+ regulatory T cells. , 2006, Blood.

[65]  K. Tung,et al.  Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node , 2005, The Journal of experimental medicine.

[66]  H. Schild,et al.  NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells , 2005, The Journal of experimental medicine.

[67]  D. McDermott,et al.  Interleukin (IL)-15 and IL-2 Reciprocally Regulate Expression of the Chemokine Receptor CX3CR1 through Selective NFAT1- and NFAT2-dependent Mechanisms* , 2004, Journal of Biological Chemistry.

[68]  George Coukos,et al.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.

[69]  J. Neilson,et al.  Calcineurin B1 is essential for positive but not negative selection during thymocyte development. , 2004, Immunity.

[70]  J. Buer,et al.  Developmental Stage, Phenotype, and Migration Distinguish Naive- and Effector/Memory-like CD4+ Regulatory T Cells , 2004, The Journal of experimental medicine.

[71]  D. Klatzmann,et al.  Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State , 2003, The Journal of experimental medicine.

[72]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[73]  Ash A. Alizadeh,et al.  Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[74]  C. Thompson,et al.  The CD28 signaling pathway regulates glucose metabolism. , 2002, Immunity.

[75]  O. Acuto,et al.  CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. , 2001, Immunity.

[76]  Wolfgang Weninger,et al.  Migratory Properties of Naive, Effector, and Memory Cd8+ T Cells , 2001, The Journal of experimental medicine.

[77]  J. Bluestone,et al.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.

[78]  T. Strom,et al.  Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance , 1999, Nature Medicine.

[79]  Christoph W. Turck,et al.  Nuclear Export of NF-ATc Enhanced by Glycogen Synthase Kinase-3 , 1997, Science.

[80]  C. Thompson,et al.  CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.

[81]  V. Godfrey,et al.  Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[82]  L. Kane,et al.  CARMA1 is required for Akt-mediated NF-kappaB activation in T cells. , 2006, Molecular and cellular biology.

[83]  A. Rudensky,et al.  Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo , 2002, Nature Immunology.